C56 D07.3 D39.1
Conditions
Interventions
Group 1: Retrospective data collection:
In the retrospective phase of the study, a chart review of the patients with histologically confirmed OGCTs and SCSTs as identified from hospital records and/or
Sponsors
Universitätsfrauenklinik Freiburg
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Female patients (any age) who were diagnosed with malignant OGCTs and SCSTs (ICD C56, D07.3 and D 39.1) or dermoid cysts with immature/malign somatic components starting from January 2001 to 2011. All centers must be able to provide paraffin embedded tumor slides for each patient for central pathology re-assessment and if possible tumor blocks.
Exclusion criteria
Exclusion criteria: Benign OGCTs including teratomas, benign cystic mature teratomas (dermoid cysts).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival (OS) and progression-free survival (PFS), calculated from the day of diagnosis (day of surgery, PFS and OS after relapse are calculated from the day of relapse) in relation to treatment strategies for OGCTs and SCSTs | — |
Secondary
| Measure | Time frame |
|---|---|
| Reproductive outcomes (pregnancy rates and births), quality of life, sexual life in relation to treatment strategies for OGCTs and SCSTs. | — |
Countries
Germany
Contacts
Public ContactMaximilian Klar
Universitätsklinikum FreiburgFrauenklinik
Outcome results
None listed